• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于活性口袋的序列和结构特征预测蛋白质-蛋白质相互作用的成药性。

Predicting the druggability of protein-protein interactions based on sequence and structure features of active pockets.

作者信息

Dai X U, Jing Run Yu, Guo Yanzhi, Dong Yong Cheng, Wang Yue Long, Liu Yuan, Pu XueMei, Li Menglong

机构信息

College of Chemistry, Sichuan University, Chengdu, Sichuan 610064, PR China.

出版信息

Curr Pharm Des. 2015;21(21):3051-61. doi: 10.2174/1381612821666150309143106.

DOI:10.2174/1381612821666150309143106
PMID:25751259
Abstract

Protein-protein interactions (PPIs) are becoming highly attractive targets for drug discovery. Motivated by the rapid accumulation of PPI data in public database and the success stories concerning the targeting of PPIs, a machine-learning method based on sequence and structure properties was developed to access the druggability of PPIs. Here, a comprehensive non-redundant set of 34 druggable and 122 less druggable PPIs were firstly presented from the perspective of pockets. When tested by outer 5-fold cross-validation, the most representative model in discriminating the druggable PPIs from the less-druggable ones yielded an average accuracy of 88.24% (sensitivity of 82.38% and specificity of 92.00%). Moreover, a promising result was also obtained for the independent test set. Compared to other methods, the method gives a comparative performance, which is most likely due to the construction of a training set that encompasses less druggable PPIs and also the information of active pockets that have evolved to bind a natural ligand.

摘要

蛋白质-蛋白质相互作用(PPIs)正成为药物研发极具吸引力的靶点。受公共数据库中PPI数据的快速积累以及靶向PPIs的成功案例的推动,开发了一种基于序列和结构特性的机器学习方法来评估PPIs的成药潜力。在此,首先从口袋的角度给出了一组由34个可成药和122个难成药的PPIs组成的全面的非冗余集合。当通过外部5折交叉验证进行测试时,在区分可成药PPIs和难成药PPIs方面最具代表性的模型平均准确率为88.24%(敏感性为82.38%,特异性为92.00%)。此外,独立测试集也获得了有前景的结果。与其他方法相比,该方法具有相当的性能,这很可能是由于构建了一个包含难成药PPIs以及已进化为结合天然配体的活性口袋信息的训练集。

相似文献

1
Predicting the druggability of protein-protein interactions based on sequence and structure features of active pockets.基于活性口袋的序列和结构特征预测蛋白质-蛋白质相互作用的成药性。
Curr Pharm Des. 2015;21(21):3051-61. doi: 10.2174/1381612821666150309143106.
2
Assessing the druggability of protein-protein interactions by a supervised machine-learning method.运用有监督机器学习方法评估蛋白-蛋白相互作用的成药性。
BMC Bioinformatics. 2009 Aug 25;10:263. doi: 10.1186/1471-2105-10-263.
3
Computational probing protein-protein interactions targeting small molecules.针对小分子的蛋白质-蛋白质相互作用的计算探测
Bioinformatics. 2016 Jan 15;32(2):226-34. doi: 10.1093/bioinformatics/btv528. Epub 2015 Sep 28.
4
Exploring the relationship between hub proteins and drug targets based on GO and intrinsic disorder.基于基因本体论(GO)和内在无序性探索枢纽蛋白与药物靶点之间的关系。
Comput Biol Chem. 2015 Jun;56:41-8. doi: 10.1016/j.compbiolchem.2015.03.003. Epub 2015 Mar 23.
5
DrugPred: a structure-based approach to predict protein druggability developed using an extensive nonredundant data set.DrugPred:一种基于结构的方法,使用广泛的非冗余数据集来预测蛋白质的可成药性。
J Chem Inf Model. 2011 Nov 28;51(11):2829-42. doi: 10.1021/ci200266d. Epub 2011 Oct 13.
6
Dr. PIAS 2.0: an update of a database of predicted druggable protein-protein interactions.PIAS 2.0 博士:一个预测可成药性蛋白-蛋白相互作用数据库的更新。
Database (Oxford). 2012 Oct 10;2012:bas034. doi: 10.1093/database/bas034. Print 2012.
7
RVMAB: Using the Relevance Vector Machine Model Combined with Average Blocks to Predict the Interactions of Proteins from Protein Sequences.RVMAB:使用相关向量机模型结合平均块从蛋白质序列预测蛋白质相互作用
Int J Mol Sci. 2016 May 18;17(5):757. doi: 10.3390/ijms17050757.
8
Combining global and local measures for structure-based druggability predictions.基于结构的可成药性预测的全局和局部度量的结合。
J Chem Inf Model. 2012 Feb 27;52(2):360-72. doi: 10.1021/ci200454v. Epub 2012 Jan 5.
9
Benchmark Study Based on 2P2I to Gain Insights into the Discovery of Small-Molecule PPI Inhibitors.基于 2P2I 的基准研究,深入了解小分子 PPI 抑制剂的发现。
J Phys Chem B. 2018 Mar 8;122(9):2544-2555. doi: 10.1021/acs.jpcb.7b12658. Epub 2018 Feb 22.
10
Dr. PIAS: an integrative system for assessing the druggability of protein-protein interactions.PIAS 博士:一种综合系统,用于评估蛋白质-蛋白质相互作用的成药性。
BMC Bioinformatics. 2011 Feb 9;12:50. doi: 10.1186/1471-2105-12-50.

引用本文的文献

1
Evidence for ligandable sites in structured RNA throughout the Protein Data Bank.在整个蛋白质数据库中具有配体结合位点的结构 RNA 的证据。
Bioorg Med Chem. 2019 Jun 1;27(11):2253-2260. doi: 10.1016/j.bmc.2019.04.010. Epub 2019 Apr 6.